Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ATAI has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
ATAI stock price ended at $2.33 on Wednesday, after rising4.95%
The ATAI Life Sciences NV stock price increased by 4.95% on the last trading day (18 Jun 2025), rising from 2.23 to 2.33. Throughout the last trading session, the stock experienced a fluctuation of 11.66% , ranging from a day low of $2.23 to a day high of 2.49. The price has declined in 7 of the last 10 days, resulting in a total change of -5.67% during this period. On the last day, trading volume increase by 1.09M shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 3.09M shares were traded, amounting to approximately 7.37M.
ATAI Technical Signals
ATAI(ATAI Life Sciences NV Corp) has 4 buy signals and 1 sell signal now. The current trend is uptrend starting from 2025-06-13. The total price change during this trend is +10.43%. Recently, the price has increased significantly with an increase in volume, indicating a strong bullish signal. The average turnover of ATAI over the last 5 trading days is 4.77M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
ATAI Moving Average Analysis
ATAI Life Sciences NV's overall moving average trend leans more bullish as of Friday, June 20, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $2.597153333333333, and $2.7843333333333327. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $1.991513333333333, and $1.8043333333333331. A break-down below any of these levels will issue sell signals.
ATAI Short Selling Analysis
The short sale ratio of ATAI Life Sciences NV(ATAI) as of 17 Jun 2025 is 13.66%, dropping from last trading day. With decreasing price from 2.24 to 2.22. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary
Sell
1
Buy
4
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.265
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.131
Bullish
Moving Average
Price crosses above 10-day SMA
--
Bullish
Moving Average
Price crosses above 20-day SMA
--
Bullish
1 Bearish Signals
1 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 < 0
-0.14
Bearish
ATAI Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to ATAI Life Sciences NV(ATAI), our algorithm predicts ATAI's 1-month price at $2.04, with an -3.13%downwardshift. Using a similarity score up to 98.90%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for ATAI Life Sciences NV (ATAI.O) stock, as of Sunday, June 15, 2025 , forecasts a -3.13% change over the next month, based on its high correlation with TK.N stock patterns. The similarity between their price movements over the analyzed periods is 98.9%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
ATAI
No Data
TK
Down: -3.13%Similarity: 98.9%
Name
Similarity
Up/Down
TK.N
98.90%
-3.13%
BBY.N
98.86%
+22.49%
SAP.N
98.83%
+4.62%
ANGO.O
98.75%
+4.99%
FSM.N
98.68%
-11.33%
SONY.N
98.68%
+21.29%
IBM.N
98.66%
+3.86%
SWKS.O
98.62%
-4.68%
PEGA.O
98.60%
-2.26%
ADEA.O
98.56%
+10.85%
ATAI Seasonality Analysis
Based on ATAI's historical stock price data across all years, the probability of a positive return in June is25.00%, suggesting it maynotbe an ideal month to invest in ATAI. In contrast,Julyoffers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying ATAI Life Sciences NV (ATAI.O) stock in July has the highest probability of a positive return (100.00%), while September has the lowest probability (0.00%).
Performance Seasonality
The chart shows ATAI Life Sciences NV. (ATAI)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy ATAI Life Sciences NV (ATAI.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ATAI has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying ATAI Life Sciences NV (ATAI.O) stock in a year?
The radar chart shows that buying ATAI Life Sciences NV (ATAI.O) stock in July has the highest probability of a positive return (100.00%), while September has the lowest probability (0.00%).
How has ATAI Life Sciences NV. (ATAI)'s stock price performed over the past three years?
ATAI's stock price fell by -46.79% in 2023,decreased by -21.30% in 2024, and went up by 45.62% in 2025.
Bearish technical signals of ATAI include: MOM_10 < 0.
Is ATAI a buy based on overall technical signals summary?
ATAI has 4 buy signals and 1 sell signals now. Overall the technical rating for ATAI is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of ATAI.
What is the trend of ATAI Life Sciences NV (ATAI)'s moving average?
ATAI Life Sciences NV's overall moving average trend leans more bullish as of June 20 2025, with 1 negative signals and 3 positive signal.
What is price prediction for ATAI stock next month?
The price prediction chart for ATAI Life Sciences NV (ATAI.O) stock, as of June 15 2025, forecasts a -3.13% change over the next month, based on its high correlation with TK stock patterns. The similarity between their price movements over the analyzed periods is 98.9%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for ATAI Stock?
ATAI Life Sciences NV (ATAI) stock is predicted to reach **$2.50 by year-end 2025**, driven by its merger with Beckley Psytech and upcoming Phase 2b trial results for BPL-003 in treatment-resistant depression. The stock currently trades at $2.23, with a potential upside to **$10** based on HC Wainwright's target.
What is price prediction 2030 for ATAI Stock?
### **Price Prediction for ATAI Stock in 2030**
Based on the merger with Beckley Psytech and the strong pipeline, ATAI stock is predicted to reach **$15** by 2030. The merger positions ATAI as a leader in psychedelic therapies, with key catalysts like the Phase 2b data for BPL-003 expected mid-2025.